Şanlı, F., Barlak, N., Kılınç, A., Çapık, Özel, Aytatlı, A., & Karatas, O. F. (2020). The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells. The European Research Journal, 6(5), 380-387. https://doi.org/10.18621/eurj.624088